The Impact of Pharmacists' Interventions on the Quality of Life of HIV-TB Co-infection Outpatients in Indonesia
Conditions:   Pharmaceutical Care;   HIV/AIDS;   Tuberculosis Intervention:   Other: Pharmaceutical Care Sponsors:   Bekasi City Public Hospital;   University of Groningen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2020 Category: Research Source Type: clinical trials

Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study
Conditions:   HIV;   Tuberculosis Interventions:   Drug: Clofazimine (CFZ);   Drug: Rifapentine (RPT);   Drug: Isoniazid (INH);   Drug: Pyrazinamide (PZA);   Drug: Ethambutol (EMB);   Drug: Rifampicin (RIF);   Dietary Supplement: Pyridoxine (vitamin B6) Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2020 Category: Research Source Type: clinical trials

A Study in Two Panels of Healthy Adult Participants to Assess Single-Dose Immediate-Release and Single-Dose Dispersible Formulations of Pretomanid
Condition:   Multi-drug Resistant Tuberculosis Intervention:   Drug: Pretomanid Sponsor:   Global Alliance for TB Drug Development Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2020 Category: Research Source Type: clinical trials

Xpert Active Case-finding Trial 3 (XACT-3)
Condition:   Tuberculosis Interventions:   Other: GeneXpert Edge;   Other: GeneXpert Ultra Sponsors:   University of Cape Town;   Zambart (University of Zambia), Zambia;   Instituto Nacional de Saúde, Mozambique;   Biomedical Research and Training Institute, Zimbabwe;   Radboud University;   London School of Hygiene and Tropical Medicine;   University of Cape Town Lun g Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2020 Category: Research Source Type: clinical trials